Mental Health

Compass Pathways to announce first quarter financial results on May 8, 2024

LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access…

7 months ago

Anxiety Canada Breaking Barriers to Mental Health Support

Collaboration with TELUS Health expands access to therapy for people in Canada through exceptional personalized counsellingTORONTO, ON / ACCESSWIRE /…

7 months ago

Safe Supply Streaming: Pioneering Solutions in the Addiction Crisis through Strategic Partnerships and Innovation

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply"…

7 months ago

Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

This innovative collaboration will help improve adoption of measurement-based care and precision psychiatry to enhance diagnostic and treatment practicesSAN FRANCISCO--(BUSINESS…

7 months ago

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;…

7 months ago

VitalHub Announces Q1 2024 Conference Call Date

TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI) (OTCQX:VHIBF) is pleased to announce…

7 months ago

MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month

VANCOUVER, BC / ACCESSWIRE / May 2, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a clinical stage…

7 months ago

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearanceMALVERN, Pa., May…

7 months ago

MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3

VANCOUVER, BC / ACCESSWIRE / May 1, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to…

7 months ago